API | TC99M nofetumomab merpentan

TC99M nofetumomab merpentan (Verluma) Report issue

Biologics mAb Imaging Approved ^FDA

ChEMBL DrugBank Drug Central KEGG MeSH

Active Ingredient History

NOW

Technetium (99mTc) nofetumomab merpentan is a mouse monoclonal antibody derivative used in the diagnosis of lung cancer, gastrointestinal, breast, ovary, pancreas, kidney, cervix, and bladder carcinoma. The antibody part, nofetumomab, is attached to the chelator merpentan, which links it to the radioisotope technetium-99m (99mTc). ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
technetium tc 99m nofetumomab merpentan

More Chemistry

Pharmacology

Mechanisms of Action:
- B-lymphocyte antigen CD20 (Homo sapiens) ^UniProt
Multi-specific: No
Imaging: 99-Technetium
Black Box: No
Availability: Prescription Only
Delivery Methods: Parenteral
Pro Drug: No

Organizations (1)

Research & Development (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (1)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (1)

Approved Indications (1)

Diagnostic Imaging (approved 1996)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue